# Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes

> **NCT00276393** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 22 (—)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Basal insulin

## Key facts

- **NCT ID:** NCT00276393
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 22 (—)
- **Last updated:** 2011-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276393, "Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00276393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*